Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Infections Escherichia coli

Strauch, E. Schaudinn, C. Beutin, L. First-time isolation and characterization of a bacteriophage encoding the Shiga toxin 2c variant, which is globally spread in strains of Escherichia coli 0157. Infect. Immun. 2004,72, 7030-7039. [Pg.223]

McNally, A., Roe, A. J., Simpson, S., Thomson-Carter, F. M., Hoey, D. E., Currie, C, Chakraborty, T., Smith, D. G., and Gaily, D.L (2001). Differences in levels of secreted locus of enterocyte effacement proteins between human disease-associated and bovine Escherichia coli 0157. Infect. Immun. 69, 5107-5114. [Pg.202]

Starnes, H. F Pearee, M. K., Tewari, A., Yim, H. H., Zou, J. C., and Ambrams, J. S., Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-a challenge in mice. J. Immunol. 145,4185-4191 (1990). [Pg.128]

Thielman NM, Guerrant RL Enteric Escherichia coli infections in Guerrant RL, Walker DH, Weller PF (eds) Tropical Infectious Diseases Principles, Pathogens, and Practice. Philadelphia, Churchill Livingstone, 1999, pp 261-276. [Pg.32]

Guerrant RL, Brunton LL, Schnaitman RC, Rebhun LI, Gilman AG Cyclic adenosine monophosphate and alteration of Chinese hamster ovary cell morphology A rapid, sensitive in vitro assay for the entertoxins of Vibrio cholerae and Escherichia coli. Infect Immun 1974 10 320-327. [Pg.33]

Knutton S, Baldwin T, Williams PH, McNeish AS Actin accumulation at sites of bacterial adhesion to tissue culture cells Basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun 1989 57 1290-1298. [Pg.33]

Navarro-Garcia F, Eslava C, Villaseca JM, Lo-pez-Revilla R, Czeczulin JR, Srinivas S, Nataro JP, Cravioto A In vitro effects of a high-molecular-weight heat-labile enterotoxin from enteroaggregative Escherichia coli. Infect Immun 1998,66 3149-3154. [Pg.33]

Fasano A, Kay BA, Russell RG, Maneval DR Jr, Levin MM Enterotoxin and cytotoxin production by enteroinvasive Escherichia coli. Infect Immun 1990,58 3717-3723. [Pg.33]

Doughty, S., Sloan, J., Bennett-Wood, V., Robertson, M., Robins-Brown, R. M., and Hartland, E. L. (2002). Identification of a novel fibrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli. Infect. Immun. 70, 6761-6769. [Pg.144]

Langermann, S., Palaszynski, S., Barnhart, M., Auguste, G., Pinkner, J. S., Burlein, J., Barren, P., Koenig, S., Leath, S., Jones, C. H., and Hultgren, S. J. (1997). Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systematic vaccination. Science 276, 607-611. [Pg.151]

Moon, H. W., and Bunn, T. O. (1993). Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals. Vaccine 11, 200-213. [Pg.153]

Ono, E., Abe, K., Nakazawa, M., and Naiki, M. (1989). Ganglioside epitope recognized by K99 fimbriae from enterotoxigenic Escherichia coli. Infect. Immun. 57, 907-911. [Pg.154]

Parkkinen, J., Rogers, G. N., Korhonen, T., Dahr, W., and Finne, J. (1986). Identification of the O-linked sialyloligosaccharides of glycophorin A as the erythrocyte receptors for S-fimbriated Escherichia coli. Infect. Immun. 54, 37-42. [Pg.155]

Selvarangan, R., Goluszko, P., Popov, V., Singhal, J., Pham, T., Lublin, D. M., Nowicki, S., and Nowicki, B. (2000). Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli. Infect. Immun. 68,1391-1399. [Pg.157]

Smit, H., Gaastra, W., Kamerling, J. P., Vliegenthart, J. F. G., and DeGraff, F. K. (1984). Isolation and structural characterization of the equine erythrocyte receptor for enterotoxigenic Escherichia coli. Infect. Immun. 46,578-584. [Pg.158]

Visai, L., Speziale, P., and Bozzini, S. (1990). Binding of collagens to an enterotoxigenic strain of Escherichia coli. Infect. Immun. 58, 449-455. [Pg.160]

The same liposomal preparation was used to investigate the effect of the administered dose on the biodistribution and pharmacokinetics (41). The effect of the lipid dose of Tc-HYNIC-PEG-liposomes was investigated in the low-dose range (0.02-1.0 pmol/kg), typically for noninvasive imaging applications. The biodistribution and pharmacokinetics of "Tc-HYNIC-PEG-liposomes at various dose levels were studied in rats and rabbits with a focal Escherichia coli infection. Moreover, the pharmacokinetics of Tc-HYNIC-PEG-liposomes at two lipid dose levels were studied in four patients. In rabbits, enhanced clearance was observed at a dose level of 0.02 pmol/kg. The circulatory half-life decreased from 10.4 to 3.5 hours (at 1.0 and 0.02 pmol/kg, respectively). At the lowest dose level, liposomes were mainly taken up by the liver and to a lesser extent by the spleen. Most importantly, the rapid clearance of low-dose PEG liposomes was also observed in humans when relatively low lipid doses were administered as is shown in Figure 4. This study showed that, at very low lipid doses, the biodistribution of PEG liposomes is dramatically altered. [Pg.181]

Naimi, T. S., Wicklund, J. H., Olsen, S. J., Krause, G., Wells, J. G., Bartkus, J. M., Boxrud, D. J., Sullivan, M., Kassenborg, H., Besser, J. M., Mintz, E. D., Osterholm, M. T., et al. (2003). Concurrent outbreaks of Shigella sonnei and enterotoxigenic Escherichia coli infections associated with parsley Implications for surveillance and control of foodborne illness. J. Food Prot. 66,535-541. [Pg.203]

Teraguchi, S., Shin, K., Fukuwatari, Y., and Shimamura, S. (1996). Glycans of bovine lacto-ferrin function as receptors for the type 1 fimbrial lectin of Escherichia coli. Infect. Immun. 64,1075-1077. [Pg.79]

Hiraga, S. Sugino, Y. Nucleoside monophosphokinases of Escherichia coli infected and uninfected with an RNA phage. Biochim. Biophys. Acta, 114, 416-418 (1966)... [Pg.554]

Harrington SM, Dudley EG, NataroJP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006 254 12-18. [Pg.520]

Bullen, J.J., Rogers, H.J., and Leigh, L. 1972. Iron-binding proteins in milk and resistance to Escherichia coli infections in infants. Br. Med. J. 1, 69—75. [Pg.251]

Chamberlin, M., McGrath, J., and Waskell, L. (1970). New RNA Polymerase Form Escherichia coli Infected with Bacteriophage T7. Nature 228 227. [Pg.367]

B24. Bourgeau, G., Lapointe, H., Peloquin, P, and Mayrand, D., Cloning expression, and sequencing of a protease gene (tpr) from Porphyromonas gingivalis W83 in Escherichia coli. Infect. Immun. 60(8), 3186-3192(1992). [Pg.91]

Extracts of cells - of Escherichia coli infected with a T-even bacteriophage contain an enzyme deoxycytidylate hydroxymethylase which is not detected in uninfected cells it catalyzes the formation of 6 -(hydroxymethyl)-2-deoxyc3didylic acid from formaldehyde and 2-deoxycytidyUc acid in the presence of tetrahydrofolic acid and magnesium ions. In a large-scale experiment, 10.6 mg. of the barium salt was prepared. [Pg.233]

Zeng, Z.-L. Fung, K. (1997) Effects of experimentally induced Escherichia coli infection on the pharmacokinetics of enrofloxacin in pigs. Journal of Veterinary Pharmacology and Therapeutics, 20 (Suppl. 1), 39-40. [Pg.135]

Dalrymple SA, Slattery R, Aud DM, et al. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun 1996 64 3231-5. [Pg.727]

Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, Cheung CC, Mak TW (2006) Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A 103(6) 1834-1839. doi 10.1073/pnas.0510847103... [Pg.476]

Karch H, Bielaszewask M, Bitzan M, et al. Epidemiology and diagnosis of shiga toxin-producing Escherichia coli infections. Diagn Microbiol Infect Dis 1999 34 229-243. [Pg.2052]

Kehl KS, Havens P, Behnke CE, Acheson DW (1997) Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J Clin Microbiol 35 2051-2054 Konowalchuk J, Speirs Jl, Stavric S (1977) Vero response to a cytotoxin of Escherichia coli. Infect Immun 18 775-779... [Pg.84]

Paton JC, Paton AW (1998b) Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Chn Microbiol Rev 11 450-479... [Pg.85]

Rosen H, Michel BR. Redundant contribution of myeloperoxidase dependant systems to neutrophil-mediated killing of Escherichia coli. Infect Immun 1997 65 4173-8. [Pg.368]

Bohach G, Hauser A, Schlievert P Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherichia coli. Infect Immun 1988 56 1665-1667. [Pg.19]


See other pages where Infections Escherichia coli is mentioned: [Pg.323]    [Pg.139]    [Pg.108]    [Pg.316]    [Pg.731]    [Pg.144]    [Pg.157]    [Pg.73]    [Pg.204]    [Pg.575]    [Pg.431]    [Pg.254]    [Pg.454]    [Pg.1966]    [Pg.3714]    [Pg.1013]    [Pg.81]   


SEARCH



Escherichia coli 0157 infection outbreak

Escherichia coli infection resistance

Escherichia coli infection treatment

Escherichia coli infections antibiotics

Escherichia coli infections caused

Escherichia coli infections enterotoxigenic

Escherichia coli infections peritonitis

Escherichia coli infections procedures

Escherichia coli infections sepsis

Escherichia coli intestinal infections with

Escherichia coli urinary tract infection

Events That Follow Infection of Escherichia coli by Bacteriophage A Can Lead to Lysis or Lysogeny

© 2024 chempedia.info